Catalyst Wire Dossier Catalyst Wire Dossier

Repaglinide

Repaglinide · Novo Nordisk
Drug timelines are a Plus or Pro feature.

43 regulatory and trial events tracked for Repaglinide, covering 2006-06-13 to 2026-08-07. Get the full timeline:

Most recent: FDA Approved: REPAGLINIDE — Supplemental Application (Macleods Pharmaceuticals Limited)

See pricing